|
|
|
HEME BIOSYNTHETIC PATHWAY (PW:0000218)
DescriptionModified tetrapyrroles, such as hemes and chlorophylls, are the most abundant pigments found in nature. Heme is an iron-containing prosthetic group that is an essential constituent of proteins such as hemoglobin, myoglobin and cytochromes. All of heme's carbon and nitrogen atoms can come from acetate and glycine. Succinyl-CoA, from actetate metabolized in the citric acid cycle, is condensed with glycine by delta-aminolevulinic acid synthase (Alas) to form delta-aminolevulinic acid (ALA) in the mitochondrion. There are two Alas isoenzymes: one (Alas1) is ubiquitously expressed, while the other (Alas2) is only expressed in erythroid cells. Transported to the cytosol, two ALAs are combined by delta-aminolevulinate dehydratase (Alad) to generate porphobilinogen (PBG). Four PBG molecules are condensed by hydroxymethylbilane (or porphobilinogen) synthase (Hmbs) to form the linear tetrapyrrole hydroxymethylbilane, which is then cyclized by uroporphyrinogen III synthase (Uros; aka porphobilinogen deaminase) to form uroporphyrinogen III. Uroporphyrinogen decarboxylase (Urod) subsequently decarboxylates all four acetate groups of uroporphyrinogen III to form the methyl groups of coproporphyrinogen III. As coproporphyrinogen III is being transported back into the mitochondrion, coproporphyrinogen oxidase (Cpox) decarboxylates two of its propionate side chains to form the vinyl groups of protoporphyrinogen IX. Protoporphyrinogen oxidase (Ppox) then oxidizes the methylene groups connecting the pyrrole rings to form the methenyl linkages of protoporphyrin IX. In the final reaction of the heme biosynthetic pathway, ferrochetalase (Fech) , inserts ferrous iron into protoporphyrin IX to generate heme. Heme is synthesized mainly in erythroid cells, with the remainder generated in the liver. In the latter location, heme regulates its own synthesis by feedback inhibition of the pathway's first enzyme, Alas. In erythroid cells, heme synthesis is regulated by iron availability and shuts down as the cells mature. Alterations of the pathway due to mutations in its enzymes are associated with a number of diseases, most notably porphyrias. To
see the Ontology
Report for annotations GViewer and download click here[Click here to see the ontology report for
associated GO
term - GO:0006695
and entry at Reactome - REACT_9465.1] ...(less)
|
Pathway Diagram:
|
|
|
Genes in Pathway:
heme biosynthetic pathway
|
| G |
Alad |
aminolevulinate dehydratase |
|
|
IEA |
5 |
79,505,645 |
79,515,983 |
RGD:1578396 |
RGD |
| G |
Alad |
aminolevulinate dehydratase |
|
|
ISS |
5 |
79,505,645 |
79,515,983 |
RGD:4144542 |
RGD |
| G |
Alas1 |
aminolevulinate, delta-, synthase 1 |
|
|
ISS |
|
|
|
RGD:4144542 |
RGD |
| G |
Alas1 |
aminolevulinate, delta-, synthase 1 |
|
|
IEA |
|
|
|
RGD:1578396 |
RGD |
| G |
Alas1 |
aminolevulinate, delta-, synthase 1 |
|
|
IDA |
|
|
|
RGD:1601233 |
RGD |
| G |
Alas2 |
aminolevulinate, delta-, synthase 2 |
|
|
ISS |
|
|
|
RGD:4144542 |
RGD |
| G |
Alas2 |
aminolevulinate, delta-, synthase 2 |
|
|
IEA |
|
|
|
RGD:1578396 |
RGD |
| G |
Cpox |
coproporphyrinogen oxidase |
|
|
ISS |
11 |
42,748,703 |
42,758,686 |
RGD:4144542 |
RGD |
| G |
Cpox |
coproporphyrinogen oxidase |
|
|
IEA |
11 |
42,748,703 |
42,758,686 |
RGD:1578396 |
RGD |
| G |
Fech |
ferrochelatase |
|
|
ISS |
18 |
60,675,217 |
60,708,418 |
RGD:4144542 |
RGD |
| G |
Fech |
ferrochelatase |
|
|
IEA |
18 |
60,675,217 |
60,708,418 |
RGD:1578396 |
RGD |
| G |
Hmbs |
hydroxymethylbilane synthase |
|
|
IDA |
8 |
47,314,235 |
47,321,604 |
RGD:2301704 |
RGD |
| G |
Hmbs |
hydroxymethylbilane synthase |
|
|
ISS |
8 |
47,314,235 |
47,321,604 |
RGD:4144542 |
RGD |
| G |
Hmbs |
hydroxymethylbilane synthase |
|
|
IEA |
8 |
47,314,235 |
47,321,604 |
RGD:1578396 |
RGD |
| G |
Ppox |
protoporphyrinogen oxidase |
|
|
ISS |
13 |
87,170,602 |
87,174,740 |
RGD:4144542 |
RGD |
| G |
Ppox |
protoporphyrinogen oxidase |
|
|
IEA |
13 |
87,170,602 |
87,174,740 |
RGD:1578396 |
RGD |
| G |
Ppox |
protoporphyrinogen oxidase |
|
|
IDA |
13 |
87,170,602 |
87,174,740 |
RGD:1599180 |
RGD |
| G |
Urod |
uroporphyrinogen decarboxylase |
|
|
ISS |
5 |
137,296,410 |
137,300,496 |
RGD:4144542 |
RGD |
| G |
Urod |
uroporphyrinogen decarboxylase |
|
|
IEA |
5 |
137,296,410 |
137,300,496 |
RGD:1578396 |
RGD |
| G |
Urod |
uroporphyrinogen decarboxylase |
|
|
IDA |
5 |
137,296,410 |
137,300,496 |
RGD:2303399 |
RGD |
| G |
Uros |
uroporphyrinogen III synthase |
|
|
TAS |
1 |
193,184,946 |
193,205,475 |
RGD:4144823 |
RGD |
| G |
Uros |
uroporphyrinogen III synthase |
|
|
IEA |
1 |
193,184,946 |
193,205,475 |
RGD:1578396 |
RGD |
| G |
Uros |
uroporphyrinogen III synthase |
|
|
ISS |
1 |
193,184,946 |
193,205,475 |
RGD:4144542 |
RGD |
|
|
|
Pathway Gene Annotations |
|
Disease Annotations Associated with Genes in the heme biosynthetic pathway
|
|
|
|
| Alad | Acute Kidney Injury , Arsenic Poisoning , Diabetes Mellitus, Experimental , Fatigue , Hypertension , Hypothyroidism , Lead Poisoning , Manganese Poisoning , Porphyria, Acute Hepatic , Porphyrias, Hepatic , Seizures , Status Epilepticus | | Alas1 | Diabetes Mellitus, Experimental , Hypertension, Pulmonary , Porphyrias , Rhabdomyolysis , Sepsis | | Alas2 | Anemia, Hemolytic , Anemia, Sideroblastic , PROTOPORPHYRIA, ERYTHROPOIETIC, X-LINKED , X-linked sideroblastic anemia | | Cpox | Arthritis, Experimental , Coproporphyria, Hereditary , Liver Diseases , Porphyrias, Hepatic | | Fech | Porphyria, Erythropoietic , Porphyrias, Hepatic , Protoporphyria, Erythropoietic | | Hmbs | Diabetes Mellitus, Experimental , Hyperbilirubinemia , Hypercholesterolemia , Porphyria, Acute Intermittent , Porphyrias, Hepatic , Prostatic Neoplasms , Seminoma , Urinary Bladder Neoplasms | | Ppox | Porphyria, Acute Intermittent , Porphyria, South African type , Porphyria, Variegate , Porphyrias, Hepatic | | Urod | Breast Neoplasms , Porphyria Cutanea Tarda , Porphyrias, Hepatic | | Uros | Porphyria, Erythropoietic | |
| Seizures | Alad | | Coproporphyria, Hereditary | Cpox | | Hypertension, Pulmonary | Alas1 | | Hypothyroidism | Alad | | Acute Kidney Injury | Alad | | Breast Neoplasms | Urod | | Anemia, Sideroblastic | Alas2 | | Liver Diseases | Cpox | | Porphyrias | Alas1 | | Urinary Bladder Neoplasms | Hmbs | | X-linked sideroblastic anemia | Alas2 | | Hypertension | Alad | | Prostatic Neoplasms | Hmbs | | Hypercholesterolemia | Hmbs | | Porphyria, Acute Intermittent | Hmbs , Ppox | | Porphyria, South African type | Ppox | | Porphyria, Variegate | Ppox | | Anemia, Hemolytic | Alas2 | | Arthritis, Experimental | Cpox | | Diabetes Mellitus, Experimental | Alad , Hmbs , Alas1 | | Fatigue | Alad | | Hyperbilirubinemia | Hmbs | | Lead Poisoning | Alad | | Rhabdomyolysis | Alas1 | | Sepsis | Alas1 | | Status Epilepticus | Alad | | Porphyria, Erythropoietic | Fech , Uros | | Porphyrias, Hepatic | Alad , Hmbs , Urod , Fech , Ppox , Cpox | | Porphyria Cutanea Tarda | Urod | | Seminoma | Hmbs | | Manganese Poisoning | Alad | | Arsenic Poisoning | Alad | | Protoporphyria, Erythropoietic | Fech | | PROTOPORPHYRIA, ERYTHROPOIETIC, X-LINKED | Alas2 | | Porphyria, Acute Hepatic | Alad | |
|
|